Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier

Magnetic Resonance Imaging

Volumn 17, Issue 1, 1999, Pages 21-27

  Heiland, Sabine ^a   Benner, Thomas ^a   Debus, Jürgen ^a   Rempp, Katrin ^a,b   Reith, Wolfgang ^a   Sartor, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SAP RESEARCH   (Germany)

Author keywords

Blood brain barrier; Contrast media; Perfusion MRI; Permeability

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; BLOOD VOLUME; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ABSCESS; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

ILEX COOKII;

EID: 0032899586     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(98)00149-0     Document Type: Article

References (22)

1. Villringer A., Rosen B.R., Belliveau J.W., Ackerman J.L., Lauffer R.B., Buxton R.B., Chao Y.S., Wedeen V.J., Brady T.J. Dynamic imaging with lanthanide chelates in normal rat brain: Contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6:1988;164-174.
2. Rosen B.R., Belliveau J.W., Vevea J.M., Brady T.J. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14:1990;249-265.
3. Albert M.S., Huang W., Lee J.H., Patlak C.S., Springer J.S. Susceptibility changes following bolus injections. Magn. Reson. Med. 29:1993;700-708.
4. Edelman R.R., Mattle H.P., Atkinson D.J., Hill T., Finn J.P., Mayman C., Routhal M., Hoogewoud H.M., Kleefield J. Cerebral blood flow: Assessment with dynamic contrast-enhanced T2-weighted MR imaging at 1.5 T. Radiology. 176:1990;211-220.
5. MGabe im Bolus. ROFO. 156:1992;212-217.
6. Reith W., Heiland S., Erb G., Benner T., Forsting M., Sartor K. Dynamic contrast-enhanced T2*-weighted MR imaging in patients with cerebrovascular disease. Neuroradiology. 39:1997;250-257.
7. Aronen H.J., Gazit I.E., Louis D.N., Buchbinder B.R., Pardo F.S., Weiskoff R.M., Harsh G.R., Cosgrove G.R., Halpern E.F., Hochberg F.H. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology. 191:1994;41-51.
8. Wenz F., Rempp K., Hess T., Debus J., Brix G., Engenhart R., Knopp M.V., van Kaick G., Wannenmacher M. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR: Am. J. Roentgenol. 166:1996;187-193.
9. Carvalho P.A., Schwartz R.B., Alexander E., Garada B.M., Zimmerman R.E., Loeffler J.S., Holman B.L. Detection of recurrent gliomas with quantitative thallium-201/technetium-99 m HMPAO single-photon emission computerized tomography. J. Neurosurg. 77:1992;565-570.
10. Steen R.G. Edema and tumor perfusion: Characterization by quantitative 1H MR imaging. Am. J. Roentgenol. 158:1992;259-264.
11. Mineura K., Sasajima T., Kowada M., Ogawa T., Hatazawa J., Shishido F., Uemura K. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer (Phila). 73:1994;2386-2394.
12. Gomori J.M., Tzuk-Shina T., Rubinstein R., Siegal T. MR cerebral blood volume maps of brain tumors. Comparison with Thallium SPECT, tumor grade, and clinical data. Intl. J. Neuroradiol. 1:1995;127-133.
13. Zierler K.L. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ. Res. 10:1962;393-407.
14. Axel L. Cerebral blood flow determination by rapidsequence computed tomography. Radiology. 137:1980;679-686.
15. Hamberg L.M., Boccalini P., Stranjalis G., Hunter G.J., Huang Z., Halpern E., Weisskoff R.M., Moskowitz M.A., Rosen B.R. Continuous assessment of relative cerebral blood volume in transient ischemia using steady state susceptibility-contrast MRI. Magn. Reson. Med. 35:1996;168-173.
16. Gowland P., Mansfield P., Bullock P., Stehling M., Worthington B., Firth J. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn. Reson. Med. 26:1992;241-258.
17. Kenny J., Schmiedl U., Maravilla K., Starr F., Graham M., Spence A., Nelson J. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA. Magn. Reson. Med. 27:1992;68-75.
18. Kennedy, S.; Szczepaniak, L.; Gibson, S.; Hilf, R.; Foster, T.; Bryant, R. Quantitative MRI of Gd-DTPA uptake in tumors: Response to photodynamic therapy. Magn. Reson. Med. 31:292-30; 1994.
19. Hittmair K., Gomiscek G., Langenberger K., Recht M., Imhof H., Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn. Reson. Med. 31:1994;567-571.
20. Tofts P.S., Berkowitz B.A. Measurement of capillary permeability from the Gd enhancement curve: A comparison of bolus and constant infusion injection methods. Magn. Reson. Imaging. 12:1994;81-91.
21. Tofts P.S., Berkowitz B.A. Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J. Magn. Reson. 102:1993;129-136.
22. Rempp K.A., Brix G., Wenz F., Becker C.R., Gückel F., Lorenz W.J. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology. 193:1994;637-641.